正在加载视频...
视频加载失败
A new study, described as the largest on human ivermectin and cancer, reportedly found that nearly half of cancers in patients saw disappearance or massive regression after six months of treatment. Nicolas Hulscher of the McCullough Foundation shared the findings, which involved patients with even late-stage cancers. The discussion... show more
20,890 次观看 • 19 天前 •via X (Twitter)
0 条评论
暂无评论
原始帖子的评论将显示在这里
![Whitney Webb, February 19, 2026: "I don't anticipate Leslie Wexner being arrested at any point. He is far too powerful... [and] he has extremely deep ties to numerous officials in the Israeli government... [and] Wexner Fellows essentially run AIPAC... one of the most powerful lobbying groups in the United States." This clip of Webb (Whitney Webb), author of One Nation Under Blackmail and contributing editor of unlimitedhangout(.)com, is taken from an interview with Clayton Morris (Clayton Morris) and Natali Morris (Natali Morris) posted to the Redacted YouTube channel (Redacted) on February 19, 2026. ---------------Partial transcription of clip---------------- "Yeah, I don't anticipate Leslie Wexner being arrested at any point. He is far too powerful, and his, his money is everywhere. And, honestly, he has extremely deep ties to numerous officials in the Israeli government through his philanthropies. He focused, pretty much the bulk of the Wexner Foundation on training up prominent figures, first in the US and the Jewish community in, in particular. And now those fellows, those Wexner fellows, essentially run AIPAC. It has an extremely close relationship with AIPAC, obviously one of the most powerful lobbying groups in the United States. "And the other side of his leadership training via his foundation has been with Israeli public officials who have, you know, these relationships as a result of that, with Wexner. And I doubt, you know, given, you know, AIPAC's influence as well as, you know, what you touched on earlier with Israel's role with Epstein, it just does not seem particularly likely in any capacity. "And I would also refer to the fact that one of the things that will never be investigated is the role of Epstein and also Wexner in this scandal that was covered up in the mid-1990s under the Clinton administration that's remembered today as Chinagate, but was obviously a lot larger than that. It was a smuggling operation that utilized Southern Air Transport, which you'll remember is the CIA front that was used to smuggle drugs and weapons during the Iran-Contra era. "After the Iran-Contra era, the Iran-Contra crowd utilized the same network again to facilitate Chinagate. And they use Southern Air Transport, which came into direct connection to be dominated in that same period of time, was dominated by Leslie Wexner and Jeffrey Epstein. And they had it relocated not that far from New Albany, Ohio, just to run, their cargo, ostensibly for the Limited, from the Rickenbacker Airport in Ohio to Hong Kong. "And people like Ohio's Inspector General called it the 'Meyer Lansky route' because he argued they were affiliated with the mob. And Columbus PD, just a few years prior, had produced a document linking Leslie Wexner to the mob and his network in the murder of the, of the lawyer for the Limited, Arthur Shapiro. "And in that document, they detailed, extensive ties of, of Wexner to organized crime affiliates. And as I noted in my book, citing Catherine Austin Fitts, she was at a— at an event and overheard a government official say that Leslie Wexner was one of the main launderers for organized crime cash flows in the United States. "And this is something, as I've detailed in my book, that Epstein was very involved with this network that involves organized crime and intelligence, specifically in allowing them to illicitly move funds and in money laundering. "And so, I mean, arguably, Epstein was a front for that, for Leslie Wexner. And this is stuff that they absolutely will, they just can't touch with a ten-foot pole without massive reverberations, you know, for the national security state of the U.S. which has, been beholden, to this, I guess, shadow government of sorts in which Epstein operated. But he was a middleman for it, he was not the head of it. "And so until there's an investigation into the people behind Epstein, including Wexner and justice there, I think most of what we're going to end up seeing is going to be superficial. And maybe more will be admitted or discovered in these Epstein files. But don't expect the government to necessarily do anything, about it."](https://image.24vids.com/tw-2024620133571023004/amplify_video_thumb/2024618294591049732/img/9Tb3JpJiPDzIMlv4.jpg)
![Whitney Webb, February 19, 2026: "[Cousin to the Rothschilds Jimmy] Goldsmith and [Robert] Maxwell basically come over [to the U.S.] and engage in these M&As, fronting for the Rothschild family... and then Epstein takes over the portfolio...[and] Evelyn de Rothschild... [was] very, very close to Jeffrey Epstein... And, again, I would argue that, if any family is untouchable, that's one of them. And I doubt investigators would get very far in probing that family." This clip of Webb (Whitney Webb), author of One Nation Under Blackmail and contributing editor of unlimitedhangout(.)com, is taken from an interview with Clayton Morris (Clayton Morris) and Natali Morris (Natali Morris) posted to the Redacted YouTube channel (Redacted) on February 19, 2026. ---------------Partial transcription of clip---------------- "But I've argued in my book that, you know, after Maxwell's death, Robert Maxwell's death in 1991, he pops up with Ghislaine in public for the first time and is for all intents and purposes the heir to Robert Maxwell's portfolio. Probably with Israeli intelligence and probably with some of the illicit financial operations that Maxwell was engaged with at the time. "And also his link with some of these organized crime networks I was talking about earlier. But why did Robert Maxwell come to the United States? He made this big entrance the into New York specifically a year or two before he died and brought Ghislaine with him. "And the reason he did that was specifically for the Rothschild banking family. And this is actually in a New York Times article that I reference in my book. I forget the exact title of the article but it's like, 'the Rothchilds' Mega Dealer' or something like that. But if you look it up on the archive dealer is spelled wrong. They switch like the E and the A for some reason, probably to make it harder for you to find. "But, basically, it says that the Rothschild banking dynasty, that at time, which was this article came out in the 1980s, they saw it as an error that they had never properly established a significant foothold on U.S. Wall Street. They had focused instead in Europe and other theaters. "And so in the 1980s, they created a Rothschild entity on Wall Street, and they had it focus on mergers and acquisitions, specifically M&As. And to do so they recorded— and to ensure their success they recruited some corporate raiders that they had a close relationship with from Britain. One of them was Robert Maxwell and the other one was Jimmy Goldsmith, who was a cousin to the Rothschilds and also involved in the same organized crime intelligence link nexus that Robert Maxwell was also tied to, via the Claremont Club, which I discuss in my book. "And Jimmy Goldsmith actually, Epstein was, met a lot of his elite friends in New York even though he's from there but in the elite circle for the first time actually at Jimmy Goldsmith's mansion in the area in the 1970s. Right after coming back from the United Kingdom on a backpacking trip when he dropped out of college, which, I would argue, it all kind of goes back to that crowd. "So Goldsmith and Maxwell basically come over and engage in these M&As, fronting for the Rothschild family specifically and then Epstein takes over the portfolio. And then, we know now, actually, it's been coming out, I think, since, there were new releases, of Epstein information, I think, in the year after my book came out. "So that would be 2023 or so, downstream of the USBI case, when it was settled. Talking about his ties to the de Rothschilds specifically, which is the French side of that banking dynasty. And if you have been paying attention, you would know for some time that Evelyn de Rothschild, in particular, very, very close to Jeffrey Epstein. "She actually wrote a letter to Bill Clinton in 1995. That he should meet Jeffrey Epstein and talk to him about currency stabilization. So this is something that's been going on for a long time. And he's been very involved with this particular family, which, it goes without saying, has extremely deep ties to the state of Israel, for an extremely long period of his career. "And, again, I would argue that, if any family is untouchable, that's one of them. And I doubt investigators would get very far in probing that family."](https://image.24vids.com/tw-2024880094834029001/amplify_video_thumb/2024877460274458624/img/PwnRWUfbX-H3Rst1.jpg)
![Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure](https://image.24vids.com/tw-2076674479695024226/amplify_video_thumb/2076674231136333824/img/S83Z7cJ1QdkerVCs.jpg)
![Oncologist Dr. William Makis describes getting attacked by the president of City of Hope cancer centers for publishing success stories using antiparasitics to treat turbo cancers: "These antiparasitics are being heavily attacked and are being suppressed every time I mention ivermectin, mebendazole, [and] fenbendazole. And I have hundreds of success stories...." This clip of Dr. Makis, a radiologist, oncologist, and cancer researcher, is taken from a panel discussion posted to the World Council for Health Rumble channel on November 24, 2025. ---------------Partial transcription of clip---------------- "So these antiparasitics are being heavily attacked, and are being suppressed every time I mention ivermectin, mebendazole, fenbendazole, and I have hundreds of success stories. I get attacked. I get attacked by mainstream doctors and mainstream oncologists. "And just going back to what Kevin McKernan said about this phenomenon of trying to retract papers, get good papers retracted, I've had this happen to me very recently. We published recently a paper on fenbendazole. Three cases of stage four cancer patients who had failed three or four or five lines of chemotherapy, and mainstream oncology regimens. These cancer patients were dying. They took fenbendazole and they became cancer free. And we followed them up, up to three years. They stayed cancer three for up to three years. So we had three cases. We published this paper a few months ago. This was only the second paper published on the antiparasitic fenbendazole in the past five years with human cases. The first one was published by Stanford University in 2021. And so they had published three cases in 2021. We published three cases in 2025. Within a month or two of the publication of our paper. Now it passed peer review and it was published. We were attacked by the editor of the paper, who's actually the president of the City of Hope cancer centers in the United States, in Atlanta, Chicago, and Phoenix. "This was Dr. Maurice [Maurie] Markman, President of City of Hope, so a big time oncologist, with a lot of, you know, big pharma funding behind him. He said he's going to pull the paper. And they didn't have a good reason to pull the paper. In fact, the reason that they were putting was that I was giving, you know, medical advice to other cancer patients with fenbendazole. And so that was some kind of a conflict of interest. And because, you know, that wasn't declared in the way they liked, that they were going to pull the paper. "And so, you know, this is an attack. We're going to see these attacks not just on Kevin McKernan and David Speicher's work in trying to make the link between Covid vaccines and these turbo cancers. But even those of us who are going to try to treat these patients, and help these patients and try to get that work published with antiparasitics and these turbo cancers, we're being attacked, and our papers are being attacked for retraction as well." #Fenbendazole #Ivermectin #Cancercure](https://image.24vids.com/tw-2072362082264047725/amplify_video_thumb/2072361878592933888/img/oHkZrV5xM-aB9mvY.jpg)
![Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." #Fenbendazole #Ivermectin #Cancercure](https://image.24vids.com/tw-1993717235274158369/ext_tw_video_thumb/1993717125651828737/pu/img/CJfuraEKnKcuCk-J.jpg)
![Oncologist Dr. William Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics, and they respond very well... [And] why do these antiparasitics work?" Todd Callender: "Cancer's a parasite?" Makis: "That's one possibility." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with attorney Todd Callender posted to the VaxxCHOICE (VaxxCHOICE) Rumble channel on November 21, 2025. ---------------Partial transcription of clip---------------- Dr. Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics and they respond very well. This is, you know, whether it's ivermectin, fenbendazole or mebendazole, these patients are responding. "Now this is very important because patients who've developed cancer after taking Covid vaccines, they don't respond usually to conventional treatments. That's one of the hallmarks of turbo cancer is they present at a very late stage. These are extremely rapidly growing tumors. They're coming in at stage four. And it's whether it's young women with breast cancer, women in their 20s, something we've never seen before, young women with, men and women with colon cancer in their 20s and 30s. "Again, we've never seen—" Callender: "Two- year-olds, I've heard of two- year-olds with colon cancer—" Dr. Makis: "—we've never seen this before. That's the incredible part. And they're not responding to conventional treatments. So, they're not responding to chemo, they're not responding to radiation therapy, immunotherapy, or if they do response, they have a very, very short response time or remission time. And then the cancer comes roaring back. "And in a lot of these tragic cases, the patient dies within six months. This is another one of the features of turbo cancer is the prognosis is extremely poor if you go the conventional route. So you need something else. Now when you're using antiparasitics, for cancer, the dose is higher than the dose you would use to treat parasites or to treat Covid. So I give just a rule of thumb for ivermectin, for example, it's about five times the dose that you would need for cancer, about 5 to 10 times the dose than if you were just treating parasites or viruses. "And to go into the— why does it work? Why do these antiparasitics work?" Callender: "Cancer's a parasite?" Dr. Makis: "Well, that's one possibility. But there's more to it than that because, out of the 400 papers that have been published, a lot of those researchers look at the mechanisms. They are trying to identify the mechanisms of how ivermectin is treating these cancers. "And you've got, for example, there was one study published a few years ago, Mexican researchers, again, you're not going to see this done in the United States, Mexico. Mexican researchers took 28 different cancer cell lines, applied ivermectin to them, and all of them responded. Now to various degrees, you had breast cancer and ovarian cancer actually responding the most to ivermectin. You had the most cancer cell killing when they were exposed to ivermectin. "But when they look at the mechanisms, they've identified a number of interesting things. For example, ivermectin shuts down and kills cancer stem cells. Now, this is important because cancer stem cells are the reason chemotherapy doesn't work. When you have stage four pancreatic cancer, stage four ovarian cancer, and you go to your oncologist, they will tell you, we will give you chemo, but we can't cure you. It's palliative chemo. It'll buy you an extra six months, an extra 12 months of life. "The reason why they say that is why the chemo is palliative, not curative. It's is because chemo cannot kill cancer stem cells, which are not rapidly dividing. Chemo will kill everything that's rapidly dividing, but cancer stem cells are not rapidly dividing. And so the chemo will kill the rapidly dividing tumor cells, and it'll leave the cancer stem cells alone, while the cancer stem cells will start rapidly dividing a year later, two years later, they're going to spread to other parts of the body. Suddenly you've got recurrence, you've got metastases. Ivermectin will shut down and kill cancer stem cells. "So imagine you, added to your chemo regimen, and now you've essentially turned what's palliative chemo or a palliative situation to potentially a curative situation. And I really do believe I've come to the point, having helped over 7,000 cancer patients in the last year, I've come to the point where I could confidently say that stage 4 pancreatic cancer is curable, stage 4 ovarian cancer is curable, stage 4 colon cancer, lung cancer. These cancers are curable. I think if you add repurposed drugs, you add antiparasitics, you can turn these into curable situations. "Now, of course, we have to prove that. We have to do the research, do the publications. But in the meantime, I say stage 4 cancer patients don't have 10 years to wait for mainstream oncology or mainstream medicine to catch up with what we're seeing already clinically, in practice."](https://image.24vids.com/tw-1993127013713166353/amplify_video_thumb/1993124339852754944/img/m5izGyXtNBTWkWd4.jpg)
